南京医药
(600713)
| 流通市值：68.10亿 | | | 总市值：69.11亿 |
| 流通股本：12.90亿 | | | 总股本：13.09亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,052,357,616.98 | 3,049,215,267.9 | 1,691,993,785.87 | 2,305,578,020.15 |
| 交易性金融资产 | 170,199,024.66 | 215,282,526.03 | 290,513,753.42 | 82,029,879.45 |
| 应收票据及应收账款 | 16,851,787,748.61 | 13,044,039,244.53 | 16,835,172,848.33 | 17,335,632,897.77 |
| 其中：应收票据 | 268,781,092.3 | 197,296,918.82 | 332,484,707.11 | 387,135,971.38 |
| 应收账款 | 16,583,006,656.31 | 12,846,742,325.71 | 16,502,688,141.22 | 16,948,496,926.39 |
| 应收款项融资 | 4,235,180,141.41 | 3,244,901,107.11 | 3,449,379,619.46 | 2,259,642,132.48 |
| 预付款项 | 1,032,136,998.85 | 975,010,006.81 | 1,050,095,194.08 | 969,136,593.58 |
| 其他应收款合计 | 877,129,976.03 | 818,207,831.58 | 947,804,648.71 | 935,027,654.56 |
| 存货 | 7,098,028,073.01 | 6,903,988,329.82 | 6,608,449,719.38 | 6,160,968,919.38 |
| 其他流动资产 | 148,381,418 | 161,097,090.66 | 130,016,789.9 | 140,591,521.27 |
| 流动资产合计 | 32,465,200,997.55 | 28,411,741,404.44 | 31,003,426,359.15 | 30,188,607,618.64 |
| 非流动资产: | | | | |
| 长期股权投资 | 89,779,418.5 | 73,795,818.67 | 67,841,370.7 | 67,514,280.13 |
| 其他权益工具投资 | 181,527,951.69 | 195,444,910.04 | 210,069,510.34 | 199,219,000.44 |
| 投资性房地产 | 102,645,162.84 | 101,143,591.61 | 85,271,769.44 | 85,738,896.23 |
| 固定资产 | 1,340,124,627.59 | 1,353,117,053.87 | 1,360,061,565.81 | 1,381,531,327.81 |
| 在建工程 | 374,296,992.57 | 349,685,556.36 | 382,257,799.96 | 342,987,857.2 |
| 使用权资产 | 294,297,901.92 | 301,173,663.71 | 306,641,668.52 | 321,201,072.09 |
| 无形资产 | 200,354,501.14 | 209,492,679.05 | 204,561,924.97 | 207,335,425.19 |
| 开发支出 | 63,632,382.19 | 50,409,079.26 | 34,191,415.17 | 29,854,112.92 |
| 商誉 | 63,244,637.68 | 63,244,637.68 | 72,166,924.65 | 72,166,924.65 |
| 长期待摊费用 | 45,122,392.8 | 47,853,550.02 | 50,996,088.47 | 48,097,820.86 |
| 递延所得税资产 | 282,680,768.95 | 271,265,746.46 | 264,870,208.71 | 257,629,604.1 |
| 其他非流动资产 | 1,568,525.8 | 2,038,119.2 | 2,697,577.56 | 3,911,204.71 |
| 非流动资产合计 | 3,039,275,263.67 | 3,018,664,405.93 | 3,041,627,824.3 | 3,017,187,526.33 |
| 资产总计 | 35,504,476,261.22 | 31,430,405,810.37 | 34,045,054,183.45 | 33,205,795,144.97 |
| 流动负债: | | | | |
| 短期借款 | 4,973,611,619.13 | 1,220,364,283.47 | 3,996,431,909.44 | 3,839,791,014.02 |
| 应付票据及应付账款 | 10,704,337,566.35 | 11,097,906,935.13 | 10,134,786,340.16 | 10,165,892,727.37 |
| 其中：应付票据 | 3,211,719,039.65 | 2,945,841,436.1 | 2,327,640,310.21 | 2,514,759,497.67 |
| 应付账款 | 7,492,618,526.7 | 8,152,065,499.03 | 7,807,146,029.95 | 7,651,133,229.7 |
| 合同负债 | 306,741,086.17 | 333,993,017.78 | 268,637,206.82 | 240,312,221.79 |
| 应付职工薪酬 | 139,213,253.44 | 212,823,515.12 | 133,748,176.85 | 131,243,110.36 |
| 应交税费 | 236,975,796.59 | 297,117,810.67 | 179,000,113.67 | 256,309,413.47 |
| 其他应付款合计 | 2,168,832,543.56 | 1,956,140,147.31 | 2,316,215,940.76 | 2,146,751,197.2 |
| 一年内到期的非流动负债 | 287,800,833.83 | 278,022,664.59 | 287,276,939.24 | 278,723,049.15 |
| 其他流动负债 | 3,613,459,877.34 | 3,124,086,320.26 | 4,129,446,445.06 | 3,637,656,022.22 |
| 流动负债合计 | 22,430,972,576.41 | 18,520,454,694.33 | 21,445,543,072 | 20,696,678,755.58 |
| 非流动负债: | | | | |
| 应付债券 | 4,112,987,911.17 | 4,146,165,413.63 | 4,120,772,719.45 | 4,112,126,302.51 |
| 租赁负债 | 176,755,190.52 | 192,066,801.91 | 190,856,499.01 | 215,068,870.64 |
| 递延收益 | 266,098,440.43 | 260,787,100.23 | 266,962,608.04 | 269,490,414.73 |
| 递延所得税负债 | 54,296,088.92 | 58,041,433.79 | 62,692,888.35 | 58,436,141.85 |
| 非流动负债合计 | 4,610,137,631.04 | 4,657,060,749.56 | 4,641,284,714.85 | 4,655,121,729.73 |
| 负债合计 | 27,041,110,207.45 | 23,177,515,443.89 | 26,086,827,786.85 | 25,351,800,485.31 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,308,892,948 | 1,308,931,630 | 1,308,929,289 | 1,308,916,414 |
| 其他权益工具 | 6,677,599.37 | 6,677,636.57 | 6,677,711.17 | 6,678,258.97 |
| 资本公积 | 2,457,563,977 | 2,453,950,805.17 | 2,454,486,224.26 | 2,450,143,350.44 |
| 减:库存股 | 43,706,552 | 51,325,807.68 | 48,343,823.35 | 48,343,823.35 |
| 其他综合收益 | 78,581,501.03 | 91,817,977.93 | 100,277,613.24 | 100,742,412.88 |
| 盈余公积 | 361,600,386.25 | 361,600,386.25 | 322,368,865.27 | 322,368,865.27 |
| 未分配利润 | 3,187,971,623.21 | 3,013,402,037.71 | 2,829,769,988.57 | 2,719,075,476.14 |
| 归属于母公司股东权益合计 | 7,357,581,482.86 | 7,185,054,665.95 | 6,974,165,868.16 | 6,859,580,954.35 |
| 少数股东权益 | 1,105,784,570.91 | 1,067,835,700.53 | 984,060,528.44 | 994,413,705.31 |
| 股东权益合计 | 8,463,366,053.77 | 8,252,890,366.48 | 7,958,226,396.6 | 7,853,994,659.66 |
| 负债和股东权益合计 | 35,504,476,261.22 | 31,430,405,810.37 | 34,045,054,183.45 | 33,205,795,144.97 |
| 公告日期 | 2026-04-30 | 2026-04-11 | 2025-10-31 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |